[1]
V. Patke and S. Saroj, “Erythrocyte enzymes of Glyoxalase system as indicators of beneficial effects of antihyperglycemic agents in Type 2 Diabetes”, Int J Res Med Sci, vol. 3, no. 7, pp. 1650–1656, Jan. 2017.